iBio, Inc.IBIONYSE
LOADING
|||
Switch Symbol:
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -100.00% | +0.00% | +0.00% | +14.29% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +620.62% | +392.03% | +165.61% | +90.44% | +513.70% |
| Weighted Average Shares Diluted Growth | +620.62% | +392.03% | +165.61% | +90.44% | +513.70% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | -100.00% | -85.27% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -34.93% | -36.23% | -61.91% | -19.31% | +161.68% |
| Book Value per Share Growth | -81.35% | -69.29% | -82.77% | -63.36% | -48.57% |
| Debt Growth | -75.05% | -76.86% | -78.34% | -21.35% | -22.18% |
| R&D Expense Growth | -18.74% | +22.28% | +110.84% | +182.81% | +172.03% |
| SG&A Expenses Growth | -15.04% | -7.40% | +9.22% | +0.51% | -10.71% |